December 12, 2008
Siemens Healthcare redefined Magnetic Resonance (MR) in Oncology with Tim (Total imaging matrix) technology at the RSNA in Chicago. Siemens offers comprehensive and state-of-the art solutions for Oncology. More
December 1, 2008
Siemens Healthcare showcases the clinical workflow of breast cancer care at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago. From early detection and diagnosis through therapy and aftercare, Siemens demonstrates its comprehensive portfolio of innovations for women’s health. More
November 27, 2008
Siemens Healthcare has introduced its new biopsy unit to the market, enhancing the Mammomat Inspiration digital mammography platform with stereotactic breast biopsy. The digital system with basic functions for screening has been on the market since the end of 2007. Since then, it has been installed in countless hospitals and private practices worldwide. The new device with its supplemental biopsy function recently went into operation in Copenhagen and Dortmund. Using the new system, all workflows are performed faster and easier than ever before. More
November 18, 2008
Siemens Healthcare is presenting one of the most innovative technologies for its Acuson S2000 ultrasound system at the Medica from November 19 – 22, 2008 in Duesseldorf, Germany. The Virtual Touch Tissue Imaging and Virtual Touch Tissue Quantification applications are the first commercially available implementations of ARFI (Acoustic Radiation Force Impulse). Similar to a physical palpation exam, these leading-edge applications represent a new dimension of diagnostic information by interrogating the mechanical strain properties or stiffness of tissue, which may be correlated with pathology. Both applications are particularly suited to evaluating liver tissue. More
June 4, 2008
Siemens Healthcare has established new research laboratories for molecular diagnostics in Cologne, Germany. The focus of the research will be on "breast cancer", a disease that remains the number one cause of death among young women despite the large number of therapies currently available. Almost 40 Siemens employees have been developing new diagnostic tests to help the treating physician find an individually optimized therapy for as many patients as possible, thus combining better chances of recovery than are now offered by today's medical state-of-the-art technology, with reduced side effects. In addition, Siemens has been researching innovative biochips to enable clinics to perform the newly developed breast cancer tests. More
March 7, 2008
Siemens Healthcare is showing its Acuson S2000, the first ultrasound system of the new product series S, at the ECR (European Congress of Radiology) 2008 in Vienna. This system platform includes integration of the newest technologies to optimize workflows and once again considerably simplify the physician's work. Thus the Acuson S2000 has been equipped with comprehensive software applications such as a new software for breast imaging. The system is also well equipped for future technologies: It enables the implementation of innovative ARFI (Acoustic Radiation Forced Impulse) imaging and is prepared for integration of new silicon ultrasound technology, which is almost ready for the market. The Acuson S2000 is suitable for internal medicine radiology imaging including vascular diagnosis and echocardiography as well as gynecology and obstetrics. More
March 7, 2008
At the European Congress of Radiology 2008 (ECR 2008) Siemens Healthcare presents its comprehensive portfolio for radiology and introduces numerous new solutions and products for the improvement of workflows in this special medical field. On the occasion of the Women's Health Days organized by the European Society of Radiology in Vienna, Siemens also places special focus on the topic of "Breast Care". The company therefore shows its Breast Care products and solutions not only at the trade show booth but also in a special trailer that is accessible to the public. More
February 15, 2008
Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease. These facts stress the importance of a quality-ensured early detection of breast cancer as well as the availability of individual therapies. In response, Siemens Healthcare developed comprehensive Breast Care Solutions for the early detection and treatment of breast cancer. These combine different imaging methods, such as ultrasound, mammography, and magnetic resonance tomography (MRT), which are supplemented by innovative software tools and solutions from lab diagnostics. More